Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (171-180 of 275) with videos related to

Pageof 28
Sort By:
Cancer Research|February 21, 2006
The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancerSteven C Smith, Gary Oxford, Zhong Wu, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.
Neoplasia (New York, N.Y.)|January 22, 2011
Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agentsSteven C Smith, Dmytro M Havaleshko, Kihyuck Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Expression of ral GTPases, their effectors, and activators in human bladder cancerSteven Christopher Smith, Gary Oxford, Alexander S Baras, et al.
Molecular & Cellular Proteomics : MCP|July 1, 2009
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitisMarion Haubitz, David M Good, Alexander Woywodt, et al.
Cancer Research|November 3, 2004
Profiling the evolution of human metastatic bladder cancerBrian E Nicholson, Henry F Frierson, Mark R Conaway, et al.
Plos One|January 12, 2013
A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressivenessLaura Grau, Jose L Luque-Garcia, Pilar González-Peramato, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2007
A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryJae K Lee, Dmytro M Havaleshko, Hyungjun Cho, et al.
Molecular Cancer Research : MCR|October 4, 2017
Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder CancerJason E Duex, Kalin E Swain, Garrett M Dancik, et al.
Plos One|March 28, 2014
Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosisSukhwinder Kaur, Navneet Momi, Subhankar Chakraborty, et al.
Pageof 28

Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
Cancer Research|February 21, 2006
The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancerSteven C Smith, Gary Oxford, Zhong Wu, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.
Neoplasia (New York, N.Y.)|January 22, 2011
Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agentsSteven C Smith, Dmytro M Havaleshko, Kihyuck Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Expression of ral GTPases, their effectors, and activators in human bladder cancerSteven Christopher Smith, Gary Oxford, Alexander S Baras, et al.
Molecular & Cellular Proteomics : MCP|July 1, 2009
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitisMarion Haubitz, David M Good, Alexander Woywodt, et al.
Cancer Research|November 3, 2004
Profiling the evolution of human metastatic bladder cancerBrian E Nicholson, Henry F Frierson, Mark R Conaway, et al.
Plos One|January 12, 2013
A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressivenessLaura Grau, Jose L Luque-Garcia, Pilar González-Peramato, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2007
A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryJae K Lee, Dmytro M Havaleshko, Hyungjun Cho, et al.
Molecular Cancer Research : MCR|October 4, 2017
Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder CancerJason E Duex, Kalin E Swain, Garrett M Dancik, et al.
Plos One|March 28, 2014
Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosisSukhwinder Kaur, Navneet Momi, Subhankar Chakraborty, et al.
Pageof 28